These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3072664)

  • 1. Does the choice of acute treatment influence future ulcer relapse?
    Bodemar G
    Scand J Gastroenterol Suppl; 1988; 155():141-51. PubMed ID: 3072664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical treatment of peptic ulcers.
    Deveney CW; Deveney KE
    Surg Annu; 1985; 17():219-33. PubMed ID: 3883541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic approach to ulcer healing.
    Blum AL
    Am J Med; 1985 Aug; 79(2C):8-14. PubMed ID: 2863981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs for treatment of peptic ulcers.
    Med Lett Drugs Ther; 1991 Nov; 33(858):111-4. PubMed ID: 1682791
    [No Abstract]   [Full Text] [Related]  

  • 5. Drugs for treatment of peptic ulcers.
    Dajani EZ; Trotman BW
    J Assoc Acad Minor Phys; 1992; 3(3):78-88. PubMed ID: 1353999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of outcome after targeted intervention for peptic ulcer resistant to acid suppression therapy.
    Lanas A; Remacha B; Sáinz R; Hirschowitz BI
    Am J Gastroenterol; 2000 Feb; 95(2):513-9. PubMed ID: 10685760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis and therapy of peptic ulcer disease.
    Peterson WL
    J Clin Gastroenterol; 1990; 12 Suppl 2():S1-6. PubMed ID: 1978840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topically active drugs in the treatment of peptic ulcers. Focus on colloidal bismuth subcitrate and sucralfate.
    Bianchi Porro G; Parente F
    J Clin Gastroenterol; 1992 Apr; 14(3):192-8. PubMed ID: 1348753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does smoking predispose to peptic ulcer relapse after eradication of Helicobacter pylori?
    Chan FK; Sung JJ; Lee YT; Leung WK; Chan LY; Yung MY; Chung SC
    Am J Gastroenterol; 1997 Mar; 92(3):442-5. PubMed ID: 9068465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current concepts in clinical therapeutics: peptic ulcer disease.
    Siepler JK; Mahakian K; Trudeau WT
    Clin Pharm; 1986 Feb; 5(2):128-42. PubMed ID: 2869852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy.
    Bianchi Porro G; Parente F; Imbesi V; Montrone F; Caruso I
    Gut; 1996 Jul; 39(1):22-6. PubMed ID: 8881802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative effectiveness and costs of antiulcer medications as a basis for rational prescribing.
    McLean AJ; Harcourt DM; McCarthy PG; Dudley FJ; McNeil JJ
    Med J Aust; 1987 Apr; 146(8):431-3, 436-8, 442. PubMed ID: 2886896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of sucralfate-induced ulcer healing and relapse.
    Lam SK
    Am J Med; 1989 Jun; 86(6A):122-6. PubMed ID: 2660554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
    Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
    Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drugs for the prevention of peptic ulcer recurrence.
    Piper DW
    Drugs; 1983 Nov; 26(5):439-53. PubMed ID: 6315333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acid and barriers. Current research and future developments for peptic ulcer therapy.
    Rademaker JW; Hunt RH
    Scand J Gastroenterol Suppl; 1990; 175():19-26. PubMed ID: 1978405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical treatment of peptic ulcer disease.
    Andersen BN
    Acta Chir Scand Suppl; 1988; 547():88-92. PubMed ID: 2906493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sucralfate and other non-antisecretory agents in the treatment of peptic ulcer disease.
    May B
    Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():113-6. PubMed ID: 2657280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of healing in peptic ulcer disease--are H2 receptor antagonists all we need?
    Korman MG
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():168-71. PubMed ID: 8103021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antacids: the past, the present, and the future.
    Lam SK
    Baillieres Clin Gastroenterol; 1988 Jul; 2(3):641-54. PubMed ID: 3048455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.